US OptionsDetailed Quotes
LLY241101C945000
- 0.02
- -0.07-77.78%
15min DelayClose Oct 31 16:00 ET
0.11High0.01Low
0.11Open0.09Pre Close33 Volume250 Open Interest945.00Strike Price181.00Turnover128.89%IV13.89%PremiumNov 1, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type0.0019Delta0.0002Gamma41487.00Leverage Ratio-0.2097Theta0.0000Rho78.21Eff Leverage0.0017Vega
Eli Lilly and Co Stock Discussion
Eli Lilly lowered guidance on lackluster sales of its blockbuster weight-loss drug Zepbound and diabetes drug Mounjaro.
(watch this Bloomberg video - Gameover!)
*********
Let me say this. If LLY stock was to go up, you might get a maximum of $200 in the next 3 months. If it drops, it's going under $500. Remember this is all my opinion, do you own research. Just look at the chart. Also, if you see so many analysts trying to pump the stock, ...
The U.S. stock market is witnessing a revival of the "Trump Trade." Shares in Trump's social media venture, $Trump Media & Technology (DJT.US)$, have soared more than 220% since Octobe...
The chart has been damaged. Don't expect a move back up without a complete test of support at 746.50. if that breaks, watch out it's a long way down. There is a hole in the ship right now, and everyone is in denial until it's too late.
Did anyone realize that LLY option chain opened around a few minutes late. I personally have never seen that before. You can add 1 plus 1 and figure out what happened. I feel sick 😫.
Please let me know if you have seen this happen before or the reason why (or at least the reason they make up).
The drop was really unjustified since the acquistion charges were higher than expected rather than lower sales number. In fact, their Zepbounds sales are up.
Latest news said that they are going to invest heavily in DTC as they have enough supplies now which will further spurn growth
No comment yet